Search
+

Colinz Laboratories Share Price

  • 42.51-1.50 (-3.40%)
  • Volume: 1,214
BSE
  • Live
  • Last Updated On: 17 May, 2024, 03:31 PM IST
Loading...

Colinz Labs share price insights

View All
  • Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 42.41% towards employee cost in the year ending 31 Mar, 2023. (Source: Standalone Financials)

  • Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)

  • Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)

  • Colinz Laboratories Ltd. share price moved down by -3.40% from its previous close of Rs 44.01. Colinz Laboratories Ltd. stock last traded price is 42.51

    Share PriceValue
    Today/Current/Last-42.51
    Previous Day-44.01

InsightsColinz Labs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    -
    EPS - TTM
    (₹)
    -
    MCap
    (₹ Cr.)
    11.09
    Sectoral MCap Rank
    163
    PB Ratio
    (x)
    1.27
    Div Yield
    (%)
    -
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-0.12
    3 Months-0.49
    6 Months-0.36
    1 Year-0.01
    3 Years0.00

    -0.12
    VWAP
    (₹)
    42.58
    52W H/L
    (₹)
    50.00 / 33.35

    Colinz Labs Share Price Returns

    1 Day-3.4%
    1 Week0.71%
    1 Month6.94%
    3 Months3.81%
    1 Year11.43%
    3 Years189.58%
    5 Years553.0%

    ET Stock ScreenersTop Score Companies

    Check whether Colinz Labs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Colinz Labs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Colinz Labs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Peer Comparison

    • Colinz Labs Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Colinz Labs21.661.275.617.814.47-1.799.116.391.824.150.030.68
      Unjha Form37.633.5111.5115.798.286.622.942.140.632.420.000.00
      Bacil Pharma-126.2710.84-9.26-9.26-9.03-6.990.000.00-0.178.190.02-0.14
      Chemo Pharma9.383.43-39.44-35.51-37.44-33.080.000.00-9.6628.820.000.00
      Kamron Labs.-128.86-10.180.00-8.69-6,858.26-46.480.000.00-7.240.05-0.8596.07
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Avon Lifesciences
      • Norris Medicine
      • Parmax Pharma
      • Brawn Biotech
      • Shyama Infosys

      Choose from Stocks

      Peers InsightsColinz Labs

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Colinz Labs Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Colinz Labs Shareholding as on 31 Mar 2024
        Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
        Promoters66.0066.0066.0066.00
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others34.0034.0034.0034.00
      • Showing Shareholding as on 31 Mar 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters16,62,65966.00 %0.00
        Pledge00.00 %0.00
        DII3,0000.12 %-
        Others8,53,44134.00 %0.00

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Colinz Labs Board Meeting/AGM

      • Colinz Labs Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        May 29, 2024May 06, 2024Board MeetingQuarterly Results
        Jan 31, 2024Jan 10, 2024Board MeetingQuarterly Results
        Oct 31, 2023Oct 16, 2023Board MeetingQuarterly Results
        Sep 29, 2023Jul 31, 2023AGMA.G.M.
        Jul 31, 2023Jul 14, 2023Board MeetingQuarterly Results
      • Dividend announcements are not available.

      • No other corporate actions details are available.

      About Colinz Labs

      Colinz Laboratories Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 11.09 Crore) operating in Pharmaceuticals sector. Colinz Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • NK

        N K Menon

        Whole Time Director
        AK

        A Krishna Kumar

        Independent Director
        VK

        Vasant K Bhat

        Independent Director
        ML

        Mani L S

        Director
        Show More
      • Sanjay R Dholakia
        Vora & Associates
        S V Bhat & Co

      Key Indices Listed on

      -

      Address

      A-101, Pratik Ind.Estate,Mulund-Goregaon Link Road,Mumbai, Maharashtra - 400078

      FAQs about Colinz Labs share

      • 1. What is Colinz Labs share price and what are the returns for Colinz Labs share?
        Colinz Labs share price was Rs 42.51 as on 17 May, 2024, 03:31 PM IST. Colinz Labs share price was down by 3.40% based on previous share price of Rs 41.4. Colinz Labs share price trend:
        • Last 1 Month: Colinz Labs share price moved up by 6.94%
        • Last 3 Months: Colinz Labs share price moved up by 3.81%
        • Last 12 Months: Colinz Labs share price moved up 11.43%
        • Last 3 Years: Colinz Labs Share price moved up by 189.58%
      • 2. What's the market capitalization of Colinz Labs?
        Within the Pharmaceuticals sector, Colinz Labs stock has a market cap rank of 163. Colinz Labs has a market cap of Rs 11.09 Cr.
      • 3. Who are peers to compare Colinz Labs share price?
        Top 10 Peers for Colinz Labs are Norris Medicines Ltd., Kobo Biotech Ltd., Adline Chem Lab Ltd., Parmax Pharma Ltd., Chemo Pharma Laboratories Ltd., Brawn Biotech Ltd., Shyama Infosys Ltd., Unjha Formulations Ltd., Bacil Pharma Ltd. and MPS Pharma Ltd.
      • 4. How can I quickly analyze Colinz Labs stock?
        Key Metrics for Colinz Labs are:
        • PE Ratio of Colinz Labs is -
        • Price/Sales ratio of Colinz Labs is 1.23
        • Price to Book ratio of Colinz Labs is 1.27
      • 5. What is Colinz Labs's 52 week high / low?
        Colinz Labs share price saw a 52 week high of Rs 50.00 and 52 week low of Rs 33.35.
      • 6. Who's the owner of Colinz Labs?
          • Promoter holding has not changed in last 9 months and holds 66.0 stake as on 31 Mar 2024
          • Other investor holding has not changed in last 9 months and holds 34.0 stake as on 31 Mar 2024
      • 7. Is the Colinz Labs profitable ?
        Total Revenue and Earning for Colinz Labs for the year ending 2023-03-31 was Rs 7.33 Cr and Rs 0.46 Cr on Standalone basis. Last Quarter 2023-12-31, Colinz Labs reported an income of Rs 1.76 Cr and profit of Rs 0.11 Cr.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times